Vivo Capital VC

Investments by market, targeted sectors and preferred funding rounds

Vivo Capital logo
Name - Vivo Capital
Description - Vivo Capital is a global healthcare investment firm that has been investing for over 20 years. Our investments across multiple funds and strategies are driven by a value and growth-oriented investment strategy, combined with extensive medical and scientific expertise. Vivo is currently making investments from its $1.4B Vivo Capital Fund IX into private healthcare companies, from
Investor Type - VC
Preferred rounds -

Investments by industry

healthtech - 17%
biotech - 67%
B2B software - 17%

Number of investments: 6

Vivo Capital invested in Ossium Health during a round worth $63,000,000 - 3/19/2021
Vivo Capital invested in Ventyx Biosciences during a round worth $114,000,000 - 3/9/2021
Vivo Capital invested in Visen Pharmaceuticals during a round worth $150,000,000 - 1/9/2021
Vivo Capital invested in dMed during a round worth $100,000,000 - 12/17/2020
Vivo Capital invested in Elevation Oncology during a round worth $65,000,000 - 11/19/2020
Vivo Capital invested in Gracell Biotechnologies during a round worth $100,000,000 - 10/29/2020